Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Each of the six major national insurers turned a profit in the first quarter of 2025, though financial pressures related to ...

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara ...

The rise in use of GLP-1 medications is driving a convergence between pharmaceutical therapies and consumer health and ...

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

New research from UC Berkeley and UC Davis suggests that knowing when and where dogs get sick can help us know when humans ...

Shilpa Medicare Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 6,214.12 Crore) operating in Pharmaceuticals sector. Shilpa Medicare Ltd. key Products/Revenue ...